Idiopathic intracranial hypertension is raised intracranial pressure without a tumor, clot or other identifiable cause. It predominantly affects young women, and its incidence has been rising. The hallmark symptoms are severe headache, pulsatile tinnitus, visual obscurations and papilledema — swelling of the optic disc.
Why measurement matters so much here
The central risk in IIH is permanent vision loss. Treatment — weight management, acetazolamide, and in some cases shunting or venous sinus stenting — aims to bring pressure down and keep it down. But confirming that pressure has actually fallen usually means another lumbar puncture, a procedure patients understandably dread and which captures only one moment in time.
The gap between visits
- Pressure in IIH varies day to day and is often highest at night
- Symptoms correlate imperfectly with measured pressure
- Visual field testing detects damage only after it has begun
- Treatment response is currently judged largely by symptom report
Long-term pressure data would let clinicians titrate treatment to physiology and intervene before the optic nerve is harmed, rather than after.
← All insights